Healthcare Services

Global Eye Melanoma Market Analysis for 2026–2030 with Strategic Forecast Insights for Businesses

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Eye Melanoma Market By 2030 Starting From Its 2026 Size?

The eye melanoma market has experienced substantial growth in recent years. This market is projected to expand from $9.86 billion in 2025 to $10.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.4%. Historically, this expansion is a result of progress in ocular imaging technologies, heightened cancer awareness, the proliferation of oncology treatment centers, enhanced diagnostic capabilities, and better survival outcomes.

The eye melanoma market is projected to experience substantial growth in the upcoming years. It is expected to expand to $15.17 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.1%. This growth during the forecast period can be attributed to the development of innovative immunotherapies, increasing adoption of precision oncology, advancements in genetic testing, rising investment in research for rare cancers, and improved early screening programs. Prominent trends for the forecast period include an intensified focus on early cancer detection, the escalating adoption of targeted and immunotherapies, expanded utilization of advanced ocular imaging, the growth of specialized oncology centers, and increasing clinical research in rare eye cancers.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13109&type=smp

What Primary Drivers Are Shaping The Development Of The Eye Melanoma Market?

The expanding occurrence of eye cancer is projected to stimulate the growth of the eye melanoma market moving forward. Eye cancer is characterized by the development of abnormal, unregulated cell proliferation within the eye’s structures. The increasing recognition and effective handling of early instances are generating a heightened requirement for specialized treatments and interventions, spurred by improved detection methods, greater awareness, and progress in therapeutic options. As an illustration, in 2025, the American Cancer Society, a US-based non-profit organization, documented approximately 3,140 new cases of eye and orbital cancers (mainly melanomas), encompassing 1,620 in males and 1,520 in females. Furthermore, approximately 490 deaths resulted from these cancers, consisting of 270 males and 220 females. Consequently, the rising prevalence of eye cancer will propel the expansion of the eye melanoma market.

Which Segment Categories Define The Eye Melanoma Market?

The eye melanoma market covered in this report is segmented –

1) By Site: Uvea, Sclera, Retina

2) By Diagnosis: Imaging, Biopsy, Eye Exam

3) By Treatment: Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment

4) By End User: Hospitals And Clinics, Academic Institutes

Subsegments:

1) By Uvea: Choroid Melanoma, Ciliary Body Melanoma, Iris Melanoma

2) By Sclera: Episcleral Melanoma, Scleral Surface Melanoma, Conjunctival Melanoma

3) By Retina: Macular Melanoma, Peripheral Retinal Melanoma, Optic Disc Melanoma

What Major Market Trends Are Driving Changes In The Eye Melanoma Market?

Leading companies in the eye melanoma market are focused on developing technological advancements like protein-kinase C (PKC) inhibitors to address the increasing demand for eye-preserving and effective systemic treatments. PKC inhibitors are small-molecule agents that specifically block PKC enzymes involved in tumor growth, presenting a non-surgical alternative to traditional therapies such as plaque brachytherapy or enucleation. For example, in March 2025, IDEAYA Biosciences, a US-based precision oncology company, introduced darovasertib, which is a first-in-class PKC inhibitor designed for uveal melanoma. This therapy targets PKC isoforms implicated in tumor proliferation, demonstrating tumor shrinkage rates of approximately 82% and eye-preservation rates of 61% in Phase 2 trials. Darovasertib is applicable to patients eligible for both enucleation and plaque brachytherapy, offering a systemic, eye-sparing choice for treating primary uveal melanoma.

Who Are The Top Companies Competing In The Eye Melanoma Market?

Major companies operating in the eye melanoma market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., Amgen Inc., Castle Biosciences Inc., IDEAYA Biosciences Inc., Delcath Systems Inc., Immunocore Holdings plc, Aura Biosciences Inc., TriSalus Life Sciences Inc., Replimune Group Inc., Linnaeus Therapeutics, iOnctura, LES LABORATOIRES SERVIER, Immatics NV

Read the full eye melanoma market report here:

https://www.thebusinessresearchcompany.com/report/eye-melanoma-global-market-report

How Does The Eye Melanoma Market Perform Across Major Global Regions?

North America was the largest region in the eye melanoma market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the eye melanoma market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Eye Melanoma Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13109&type=smp

Browse Through More Reports Similar to the Global Eye Melanoma Market 2026, By The Business Research Company

Melanoma Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/melanoma-drugs-global-market-report

Malignant Melanoma Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/malignant-melanoma-treatment-global-market-report

Melanoma Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/melanoma-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795